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Marked improvement of heart failure upon adequate titration
of continuous positive airway pressure in a patient
with obstructive sleep apnea
Znaczna poprawa kliniczna u chorego z niewydolnością serca i zespołem
obturacyjnego bezdechu sennego po właściwym ustaleniu stałego, dodatniego
ciśnienia w drogach oddechowych
Abstract
Sleep disordered breathing (SDB) is frequently present in heart failure (HF), and it may take the form of obstructive (OSA) and
central (CSA) sleep apnea. The use of continuous positive airway pressure (CPAP) in patients with OSA and HF is associated
with an improved neuroendocrine profile and cardiac function. The degree of upper airway obstruction and the airway
closing pressure (and the PAP pressure used to relieve it) may all be highly variable in a setting of uncontrolled HF, mostly
due to variable airway oedema. We present a case of a man with HF whose cardiac symptoms radically improved after
adequate treatment of his OSA with an auto-adjusting PAP device.
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Streszczenie
Zaburzenia oddychania w czasie snu często towarzyszą niewydolności krążenia i mogą przybierać postać zespołu obturacyj-
nego i ośrodkowego bezdechu sennego. Użycie aparatów wytwarzających stałe dodatnie ciśnienie w drogach oddechowych
(CPAP, continuous positive airway pressure) u chorych na niewydolność krążenia ze współistniejącym zespołem obturacyj-
nego bezdechu sennego prowadzi do poprawy profilu neuroendokrynnego i polepszenia funkcji serca. Obturacja dróg odde-
chowych (jak również ciśnienie CPAP konieczne do jej pokonania) u chorego na niewydolność krążenia może podlegać
dużym zmianom spowodowanym zmiennym obrzękiem dróg oddechowych. W niniejszej pracy przedstawiono opis pacjenta
z niewydolnością krążenia, którego objawy sercowo-naczyniowe znacząco poprawiły się w czasie leczenia wspóistniejacego
zespołu obturacyjnego bezdechu sennego po właściwym ustaleniu ciśnienia przy użyciu aparatu automatycznie dostosowu-
jącego dodatnie ciśnienie w drogach oddechowych (AutoPAP).
Słowa kluczowe: stałe dodatnie ciśnienie w drogach oddechowych, niewydolność serca
zespół obturacyjnego bezdechu sennego
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spiratory pressure of 11 cm H2O (providing main-
tenance of inspiratory airflow) and expiratory pres-
sure (controlling airway obstruction of OSA) of
7 cm H2O. He reported improvement of daytime sle-
epiness. His subjective compliance with BPAP tre-
atment was very good, with reported nightly use
of at least 6 hours. His PAP machine did not have
a compliance card.
In spite of continued therapy with spironolac-
tone 50 mg twice daily, furosemide 40 mg once
daily and carvedilol 6.25 mg twice daily his HF
remained poorly controlled. He continued to have
exertional dyspnea and dyspnea at rest, and expe-
rienced worsening peripheral oedema with an in-
crease in body weight from 236 lbs (107.3 kg) at
the time of the sleep study (body mass index, BMI
= 33.9 kg/m2) to 247 lbs (112.3 kg). No orthopnea
or paroxysmal nocturnal dyspnea was present. No
renal insufficiency, uncontrolled hypertension or
cardiac ischaemia, dietary indiscretion, heart arr-
hythmias or medication non-compliance was pre-
sent. His echocardiogram showed a moderately
enlarged left atrium, no mitral regurgitation, gros-
sly normal left ventricular size and function, and
diastolic dysfunction. He was admitted to the ho-
spital for a trial of intravenous diuretic therapy.
Physical examination on admission showed
minimal bibasilar crackles and 2+ peripheral oede-
ma; laboratory investigations demonstrated normal
basic metabolic profile and complete blood count
with mild normocytic anaemia with haemoglobin
concentration of 11.6 g/dl. Chest radiograph sho-
wed cardiomegaly (Fig. 1) and no vascular conge-
stion. He was treated with furosemide 80 mg twi-
Introduction
Sleep disordered breathing (SDB) is present in
45–76% of patients with heart failure (HF) [1, 2].
It may take the form of obstructive sleep apnea
(OSA), related to dynamic airway narrowing du-
ring sleep, and central sleep apnea (CSA), caused
by an exaggerated ventilatory response, prolonged
circulation time, and pulmonary and airway con-
gestion [3]. The use of continuous positive airway
pressure (CPAP) in patients with OSA and HF is
associated with an improved neuroendocrine pro-
file and cardiac function [4]. The degree of upper
airway obstruction and the airway closing pressu-
re (and the PAP pressure used to relieve it) may
all be highly variable in a setting of uncontrolled
HF, mostly due to variable airway oedema. We
present a case of a man with HF whose cardiac
symptoms radically improved after adequate tre-
atment of his OSA with an auto-adjusting PAP
device.
Case report
 A 71-year-old man with coronary artery dise-
ase with prior coronary artery bypass graft surge-
ry and heart failure with mildly decreased left ven-
tricular systolic function (ejection fraction of 55%)
presented for repeated sleep evaluation. One year
earlier he was diagnosed with severe obstructive
sleep apnea (OSA) with an apnea-hypopnea index
(AHI) of 55/h–1; during the PAP titration study, he
responded to bi-level positive airway pressure the-
rapy in the spontaneous mode (BPAP-S) set at in-
Figure 1. Changes in weight (Y axis, in lbs) in time (X axis, based on daily phone report) before and after institution of AutoPAP therapy
(arrow)
Rycina 1. Zmiany masy ciała (oś Y, w funtach) w czasie (oś X, na podstawie raportów telefonicznych) przed i po zastosowaniu terapii
AutoPAP (strzałka)
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ce daily; his other medications were continued at
previous doses. This therapy led to no change in
weight and minimal improvement in symptoms,
but resulted in prerenal azotaemia (blood urea ni-
trogen of 70 mg/dl and blood creatinine of 2.0 mg/dl).
Polysomnography with PAP titration was per-
formed and the optimal pressure was determined
to be 12 cm H2O. No central sleep apnea activity
was present. Given the increase in the expiratory
PAP requirement from the previous study from
7 to 12 cm H2O, an auto-adjusting PAP (AutoPAP)
set at 5-15 cm H2O was introduced and the patient
was discharged home with no change in medica-
tion profile. Over the following two weeks the pa-
tient experienced marked diuresis with improve-
ment in symptoms and decrease in weight from
247 lbs (112.3 kg) to 216 lbs (98.2 kg), documented
by daily phone weight reporting system (Fig. 2).
The patient noted less exertional dyspnea. The do-
wnload of the compliance card on his device sho-
wed that the 90th percentile pressure generated by
the machine was 11 cm H2O. The patient continu-
es to do well after six years and continues to be
compliant with his PAP treatment.
Discussion
Sleep-disordered breathing (SDB) in patients
with congestive heart failure may take the form of
obstructive and or central (CSA) sleep apnea; ap-
plication of continuous positive airway pressure
in HF patients is associated with an improved neu-
roendocrine profile and cardiac function [4]. The
beneficial effects of positive airway pressure the-
rapy in HF patients with SDB are twofold. First,
PAP treats the obstructive component of sleep-di-
sordered breathing — it acutely splints the airway,
thereby restoring airflow. This has the mechani-
cal effect of preventing wide intrathoracic pressu-
re swings and by decreasing arousals, prevents
neurohormonal activation. Second, by introducing
positive intrathoracic pressure, PAP decreases car-
diac preload, transmural left ventricular pressure,
and afterload. The net result of these pneumatic and
haemodynamic effects is typically, a decrease in car-
diac output [5]. These changes lead to improvements
in left ventricular ejection fraction, neurohormonal
profile and quality of life, and also result in reduced
airway oedema and airway resistance [6, 7].
In our patient, introduction of positive airway
pressure therapy initially led to improvement in his
daytime sleepiness although symptoms of HF conti-
nued despite apparently good compliance. A repeat
PAP titration polysomnogram identified that the expi-
ratory pressure set on his BPAP-S device was insuf-
ficient to completely control his airway obstruction.
Importantly, there was no tendency towards central
sleep apnea in the patient during that study. An
AutoPAP, a device that can adjust the pressure wi-
thin the set range in response to the variable obstruc-
tion, was then employed to assure airway patency
in the face of any changes in airway resistance rela-
ted to HF-related oedema. Subsequent to the appli-
cation of the AutoPAP at the pressure that control-
led upper airway obstruction, a marked diuresis en-
sued with concomitant resolution of HF symptoms.
Airway oedema varies with changes in the cir-
culating volume status and the PAP pressure re-
quired to keep the airway open (the ‘closing pres-
sure’) may also vary. Heart failure is a prime exam-
ple of such changes. Using an AutoPAP device in
our patient allowed a dynamic response to these
changes and full control of airway obstruction.
Complete, rather than incomplete treatment of
upper airway obstruction may result in reduction
of intrathoracic pressure swings and reduction in
preload and afterload swings. In our opinion, this
full restoration of airflow was responsible for the
patient’s clinical improvement.
AutoPAP devices are capable of adjusting the
pressure to maintain airway patency [8]. Patients
with HF, whose sleep disordered breathing may
take the form of both obstructive and central sleep
apnea, are not proven candidates for AutoPAP de-
vices and are infrequently treated with this moda-
lity. The concern is that in some HF patients, Au-
toPAP may treat the decrease in airflow due to cen-
tral sleep apnea as an airway obstruction and may
inappropriately respond to it by raising the pres-
Figure 2. Postero-anterior chest radiograph, showing cardiomegaly
and no lung parenchymal changes
Rycina 2. RTG klatki piersiowej w projekcji przednio-tylnej, widocz-
ne powiększenie sylwetki serca, brak zmian w miąższu płuc
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sure [9]. Since there are no reliable predictors of
central apneas in HF patients, polysomnography
is needed to rule out central apnea activity prior to
the introduction of an AutoPAP in this patient po-
pulation. A new bi-level positive airway pressure
device that uses adaptive servo technology with the
ability to adjust expiratory pressure promises to re-
solve both obstructive and central apnea activity [10].
In conclusion, providers caring for patients
with refractory heart failure should consider per-
forming a sleep study in patients at risk for, or with
symptoms of sleep apnea. Additionally, in patients
with known sleep apnea, incomplete treatment
should be considered. We postulate that in the
absence of central or complex sleep apnea, auto-
matically adjusting PAP devices may be useful in
managing SDB of HF patients with dynamic, volu-
me status-dependent airway size.
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